] , “A New Study Methodology: ADAPT, The Short, Staged Trial”, in 77th Annual Meeting of the College on Problems of Drug Dependence (CPDD), Phoenix, AZ, 2015.
, “Achieving Cannabis Cessation – Evaluating N-Acetylcysteine Treatment (ACCENT): Design and Implementation of a Multi-Site, Randomized Controlled Study in the National Institute on Drug Abuse Clinical Trials Network”, Contemp Clin Trials, vol. 39, pp. 211-223, 2014.
, “A Multi-Site, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence”, in College on Problems of Drug Dependence Meeting, San Juan, Puerto Rico, 2014.
, “Patient Registries for Substance Use Disorders”, Subst Abuse Rehabil, vol. 5, pp. 81-86, 2014.
, “Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World”, Contemp Clin Trials, vol. 33, pp. 993-1002, 2012.
, “How Electronic Health Records (EHRs) Can Support Comparative Effectiveness Research (CER)”, in Annual Comparative Effectiveness Research Key Function Committee Meeting, Rockville, MD, 2012.
, “Pre-existing psychiatric severity did not affect likelihood of success in the prescription opiate addiction treatment study (POATS)”, in College on Problems of Drug Dependence 74th Annual Meeting, Palm Springs, CA, 2012.
, “NIDA Clinical Trials Network (CTN) Electronic Health Records Project: Public Opportunity for Input into Standardized Common Data Elements for Drug Abuse Treatment”, in 8th Annual International Network on Brief Interventions for Alcohol Problems (INEBRIA), Boston, MA, 2011.